[Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder].
Gargot
D
D
Alexandre
L
L
Sinico
M
M
Salmeron
S
S
Benoit
G
G
Buffet
C
C
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine
Hépatite granulomateuse au cours d'une immunothérapie intravésicale pour cancer de la vessie: 3 observations.